Latest filing published 04 Mar 2013 for MAP Pharmaceuticals, Inc., €248k.
No signal scores available.
Scott Borland is a declared insider of MAP Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 4 August 2011 to 1 March 2013, the count stands at 11 filings.
The open-market record consists of 1 sale worth €14k, with no purchase. Other entries cover 4 share grants and 5 option exercises. 2013 to date brings no purchases and 1 sale.
The latest filing, published on 4 March 2013, reports a transaction of €248k in MAP Pharmaceuticals, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations